Radio Frequency Identification (RFID) In Pharmaceuticals Market Forecast Analysis Through 2030 With Insights On Industry Expansion

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Radio Frequency Identification (RFID) In Pharmaceuticals Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The market for radio frequency identification (rfid) in pharmaceuticals has experienced rapid growth in recent years. Its value is projected to expand from $6.08 billion in 2025 to $6.74 billion in 2026, at a compound annual growth rate (CAGR) of 10.9%. The historical expansion of this market can be attributed to factors such as an increasing regulatory focus on drug traceability, a rise in counterfeit medicine incidents, the expansion of global pharmaceutical supply chains, the adoption of serialization mandates, and growing hospital inventory complexity.

The market for radio frequency identification (RFID) in the pharmaceutical sector is projected to experience substantial expansion over the coming years. This market is anticipated to reach a valuation of $10.07 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.6%. This projected growth is driven by several factors including increased funding in digital pharmaceutical logistics, a heightened need for real-time insights into supply chains, the proliferation of RFID-equipped smart hospitals, wider acceptance of blockchain-integrated traceability solutions, and improved regulatory alignment across various regions. Key developments expected during this forecast period encompass the broader implementation of comprehensive drug track and trace systems, the increasing application of RFID for combating counterfeiting, stronger integration of RFID with serialization platforms, extended visibility into real-time pharmaceutical inventory, and a greater emphasis on the precision of cold chain monitoring.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25891&type=smp

Which Growth Factors Are Strengthening The Radio Frequency Identification (RFID) In Pharmaceuticals Market Landscape?

The rising occurrences of fake medications are anticipated to drive the expansion of the radio frequency identification (RFID) in pharmaceuticals market in the future. Counterfeit drugs, also known as bogus medicines, are pharmaceutical products intentionally and deceitfully mislabeled concerning their identity or source. The surge in counterfeit drug incidents stems from the rapid proliferation of online pharmacies, which has made it easier for counterfeiters to disseminate fake drugs straight to consumers, thus circumventing established regulatory protections and complicating their detection. Radio frequency identification (RFID) in pharmaceuticals aids in combating counterfeit drugs by offering secure, traceable data that confirms product legitimacy throughout each phase of the supply chain. As an illustration, in December 2024, data from the American Chemical Society, a US-based nonprofit scientific society, indicated 6,987 counterfeit drug incidents were reported across 142 countries in 2023, marking a 4% rise from 2022. Consequently, the rising instances of counterfeit drugs are fueling the expansion of the radio frequency identification (RFID) in pharmaceuticals market.

What Segment Types Are Included In The Radio Frequency Identification (RFID) In Pharmaceuticals Market Analysis?

The radio frequency identification (rfid) in pharmaceuticals market covered in this report is segmented –

1) By Type: Chipped Radio Frequency Identification, Chipless Radio Frequency Identification

2) By Component: Radio Frequency Identification Tags, Radio Frequency Identification Readers, Middleware Software, Integration Services, Data Management Software

3) By Regulatory Compliance: Food And Drug Administration Compliance Standards, European Union Falsified Medicines Directive, Good Distribution Practices, Serialization Requirements, Tracking And Tracing Regulations

4) By Application: Drug Track And Trace System, Asset Tracking, Patient Safety, Other Applications

5) By End-User: Pharmaceutical Manufacturers, Hospitals And Healthcare Providers, Pharmacies And Drug Wholesalers, Research And Development Laboratories, Logistics And Supply Chain Companies

Subsegments:

1) By Chipped Radio Frequency Identification: Low Frequency Radio Frequency Identification, High Frequency Radio Frequency Identification, Ultra High Frequency Radio Frequency Identification, Active Radio Frequency Identification, Passive Radio Frequency Identification, Semi-Passive Radio Frequency Identification

2) By Chipless Radio Frequency Identification: Time Domain Reflectometry, Frequency Domain Reflectometry, Magnetic Resonance-Based Tags, Surface Acoustic Wave Tags, Printed Conductive Polymer Tags, Photonic Band Gap Structures

Which Trends Are Guiding The Development Of The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

Major companies within the radiation toxicity treatment market are intensifying their efforts on technological advancements, particularly advanced drug delivery systems, to enhance the accuracy and efficacy of treatments, improve patient compliance, and reduce side effects. This ultimately aims to deliver superior therapeutic outcomes and accelerate recovery times. A drug delivery system is defined as a method for directing medication to specific areas of the body, thereby ensuring proper dosage and effectiveness while minimizing unwanted reactions. As an illustration, in December 2023, Coherus BioSciences, a US-based biopharmaceutical company, declared that the U.S. FDA had granted approval for UDENYCA ONBODY, which is a new on-body injector for pegfilgrastim-cbqv. This device is designed for application the day after chemotherapy to assist in lowering the risk of infection caused by febrile neutropenia. The injector delivers the medication swiftly in just five minutes and is equipped with a retractable needle for improved safety and comfort. Through this approval, Coherus seeks to offer a more convenient and user-friendly solution for managing the adverse effects of chemotherapy.

Who Are The Businesses Driving Activity In The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

Major companies operating in the radio frequency identification (rfid) in pharmaceuticals market are Fujitsu Limited, NXP Semiconductors NV, Avery Dennison Corporation, Zebra Technologies Corporation, CCL Industries Inc., HID Global Corporation, Checkpoint Systems Inc, Datalogic SpA, Impinj Inc, Schreiner Group GmbH & Co KG, Invengo Information Technology Co Ltd, GAO RFID Inc., Lowry Solutions Inc., Terso Solutions Inc., Xerafy Singapore Pte Ltd., Tageos SAS, SML Group Limited, Syrma SGS Technology Limited, Omnia Technologies Private Limited, identytag GmbH & Co KG

Access The Complete Radio Frequency Identification (RFID) In Pharmaceuticals Market Report:

https://www.thebusinessresearchcompany.com/report/radio-frequency-identification-rfid-in-pharmaceuticals-global-market-report

Which Region Holds The Largest Share In The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

North America was the largest region in the radio frequency identification (RFID) in pharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radio frequency identification (rfid) in pharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Radio Frequency Identification (RFID) In Pharmaceuticals Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=25891&type=smp

Browse Through More Reports Similar to the Global Radio Frequency Identification (RFID) In Pharmaceuticals Market 2026, By The Business Research Company

Medical Irradiation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-irradiation-global-market-report

Radiotherapy Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/radiotherapy-devices-global-market-report

Single Dose Radiotherapy Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/single-dose-radiotherapy-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info